Mochtar Riady Institute for Nanotechnology.
Mochtar Riady Institute for Nanotechnology (MRIN) was founded in 2006 as part of the Lippo Health and Medical Program, consisting of UPH Faculty of Medicine, UPH Biotechnology, Siloam Hospitals and Mochtar Riady Comprehensive Cancer Center (MRCCC).
MRIN responded to the global pandemic by doing research on Covid-19. Until today, MRIN is known to be the only private research institute in Indonesia to participate in sending genomes to GISAID, with a total of 17 sequences in May 2020 and January 2021.
To know more about MRIN, visit MRIN website
- To become an internationally recognized research center in the field of nanomedicines focusing on oncology.
- To improve the nation’s quality and competency in the field of nanomedicines through quality education and scientific discovery.
- To foster research and education in the field on nanomedicines through interdisciplinary research partnerships and collaborations
- To conduct innovative research on cancer prevention and new understandings of the cause, early diagnosis, control and cure of cancer.
Salah satu peneliti di divisi Immunology Mochtar Riady Institute for Nanotechnology Universitas Pelita Harapan (MRIN-UPH), dr. Teridah E. Ginting, DVM, PhD terl…
Mochtar Riady Institute for Nanotechnology-Universitas Pelita Harapan (MRIN-UPH) menjadi institusi riset swasta pertama di Indonesia yang resmi bekerja sama den…
Mochtar Riady Institute for Nanotechnology-Universitas Pelita Harapan (“MRIN-UPH”) officially signed a partnership agreement with the Eijkman Institute for Mole…